<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Josamycin</strong></td></tr><tr><th>Accession Number</th><td><strong>DB01321</strong></td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>A macrolide antibiotic from Streptomyces narbonensis. The drug has antimicrobial activity against a wide spectrum of pathogens. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB01321/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB01321/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01321.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01321.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01321.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01321.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01321.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB01321">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>JM</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Josamicina</td><td>Spanish</td><td>INN</td></tr><tr><td>Josamycine</td><td>French</td><td>INN</td></tr><tr><td>Josamycinum</td><td>Latin</td><td>INN</td></tr><tr><td>Leucomycin A3</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Leucomycin V, 3-acetate 4(sup B)-(3-methylbutanoate)</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate)</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Leucomycin V, 3-acetate 4B-(3-methylbutanoate)</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Josacine</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Kitasamycin A3</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Turimycin A5</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/anti-bacterial-agents">Anti-Bacterial Agents</a></li>
<li><a href="/mesh/macrolides">Macrolides</a></li></ul></td></tr><tr><th>CAS number</th><td>16846-24-5</td></tr><tr><th>Weight</th><td>Average: 827.995<br>Monoisotopic: 827.466720543</td></tr><tr><th>Chemical Formula</th><td>C<sub>42</sub>H<sub>69</sub>NO<sub>15</sub></td></tr><tr><th>InChI Key</th><td>XJSFLOJWULLJQS-NGVXBBESSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C42H69NO15/c1-23(2)19-32(47)56-40-27(6)53-34(22-42(40,8)50)57-37-26(5)54-41(36(49)35(37)43(9)10)58-38-29(17-18-44)20-24(3)30(46)16-14-12-13-15-25(4)52-33(48)21-31(39(38)51-11)55-28(7)45/h12-14,16,18,23-27,29-31,34-41,46,49-50H,15,17,19-22H2,1-11H3/b13-12+,16-14+/t24-,25-,26-,27+,29+,30+,31-,34+,35-,36-,37-,38+,39+,40+,41+,42-/m1/s1</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">(2S,3S,4R,6S)-6-{[(2R,3S,4R,5R,6S)-6-{[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(acetyloxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy}-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy}-4-hydroxy-2,4-dimethyloxan-3-yl 3-methylbutanoate</div></td></tr><tr><th>SMILES</th><td><div class="wrap">CO[C@H]1[C@H](OC(=O)C)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]1O[C@H](C)[C@@H](O[C@@H]2O[C@@H](C)[C@H](OC(=O)CC(C)C)[C@](C)(O)C2)[C@H](N(C)C)[C@H]1O</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Phenylpropanoids and Polyketides</td></tr><tr><th>Class</th><td>Macrolides and Analogues</td></tr><tr><th>Subclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Direct parent</th><td>Macrolides and Analogues</td></tr><tr><th>Alternative parents</th><td>Dihexoses; O-glycosyl Compounds; Amino Sugars; Tricarboxylic Acids and Derivatives; Oxanes; Tertiary Alcohols; Secondary Alcohols; Tertiary Amines; Carboxylic Acid Esters; Polyamines; Enolates; Alpha-hydrogen Aldehydes; Acetals</td></tr><tr><th>Substituents</th><td>disaccharide; amino sugar; tricarboxylic acid derivative; oxane; saccharide; tertiary alcohol; carboxylic acid ester; tertiary amine; secondary alcohol; alpha-hydrogen aldehyde; carboxylic acid derivative; enolate; ether; acetal; polyamine; amine; alcohol; aldehyde; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the macrolides and analogues. These are organic compounds containing a lactone ring of at least twelve members.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For the treatment of bacterial infections.</td></tr><tr><th>Pharmacodynamics</th><td>Josamycin is a macrolide antibiotic from <i>Streptomyces narbonensis</i>. The drug has antimicrobial activity against a wide spectrum of pathogens. </td></tr><tr><th>Mechanism of action</th><td>The mechanism of action of macrolides such as Josamycin is via inhibition of bacterial protein biosynthesis by binding reversibly to the subunit 50S of the bacterial ribosome, thereby inhibiting translocation of peptidyl tRNA. This action is mainly bacteriostatic, but can also be bactericidal in high concentrations. Macrolides tend to accumulate within leukocytes, and are therefore actually transported into the site of infection.</td></tr><tr><th>Absorption</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Metabolism</th><td class="data-table-container"></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Affected organisms</th><td><ul><li>Enteric bacteria and other eubacteria</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.5235</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              -
        </td>
        <td>0.9659</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.6872</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.586</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Inhibitor
        </td>
        <td>0.901</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Inhibitor
        </td>
        <td>0.901</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9274</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7897</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.9116</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Substrate</td>
        <td>0.5659</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.907</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.917</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.923</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9118</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8953</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.9564</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.8389
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9287
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            1.0
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          1.8513 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.978
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.9424
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Packagers</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Dosage forms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00404">Alprazolam</a></td><td>The macrolide, josamycin, may increase the effect of the benzodiazepine, alprazolam.</td></tr><tr><td><a href="/drugs/DB01223">Aminophylline</a></td><td>The macrolide, josamycin, may increase the effect and toxicity of the theophylline derivative, aminophylline.</td></tr><tr><td><a href="/drugs/DB00637">Astemizole</a></td><td>Increased risk of cardiotoxicity and arrhythmias</td></tr><tr><td><a href="/drugs/DB01076">Atorvastatin</a></td><td>The macrolide, josamycin, may increase the toxicity of the statin, atorvastatin.</td></tr><tr><td><a href="/drugs/DB01200">Bromocriptine</a></td><td>Erythromycin increases serum levels of bromocriptine</td></tr><tr><td><a href="/drugs/DB00490">Buspirone</a></td><td>The macrolide, josamycin, may increase the effect and toxicity of buspirone.</td></tr><tr><td><a href="/drugs/DB00564">Carbamazepine</a></td><td>The macrolide, josamycin, may increase the effect of carbamazepine.</td></tr><tr><td><a href="/drugs/DB00439">Cerivastatin</a></td><td>The macrolide, josamycin, may increase the toxicity of the statin, cerivastatin.</td></tr><tr><td><a href="/drugs/DB01166">Cilostazol</a></td><td>Erythromycin increases the effect of cilostazol</td></tr><tr><td><a href="/drugs/DB00604">Cisapride</a></td><td>Increased risk of cardiotoxicity and arrhythmias</td></tr><tr><td><a href="/drugs/DB00215">Citalopram</a></td><td>Possible serotoninergic sydrome with this combination</td></tr><tr><td><a href="/drugs/DB00363">Clozapine</a></td><td>Erythromycin increases the effect of clozapine</td></tr><tr><td><a href="/drugs/DB00091">Cyclosporine</a></td><td>The macrolide, josamycin, may increase the effect of cyclosporine.</td></tr><tr><td><a href="/drugs/DB00829">Diazepam</a></td><td>The macrolide, josamycin, may increase the effect of the benzodiazepine, diazepam.</td></tr><tr><td><a href="/drugs/DB00390">Digoxin</a></td><td>The macrolide, josamycin, may increase the effect of digoxin in 10% of patients.</td></tr><tr><td><a href="/drugs/DB00320">Dihydroergotamine</a></td><td>Possible ergotism and severe ischemia with this combination</td></tr><tr><td><a href="/drugs/DB01248">Docetaxel</a></td><td>Josamycin may increase the serum levels and toxicity of docetaxel.</td></tr><tr><td><a href="/drugs/DB00696">Ergotamine</a></td><td>Possible ergotism and severe ischemia with this combination</td></tr><tr><td><a href="/drugs/DB01023">Felodipine</a></td><td>Erythromycin increases the effect of felodipine</td></tr><tr><td><a href="/drugs/DB00472">Fluoxetine</a></td><td>Possible serotoninergic syndrome with this combination</td></tr><tr><td><a href="/drugs/DB00365">Grepafloxacin</a></td><td>Increased risk of cardiotoxicity and arrhythmias</td></tr><tr><td><a href="/drugs/DB00619">Imatinib</a></td><td>The macrolide, josamycin, may increase the serum concentration of imatinib.</td></tr><tr><td><a href="/drugs/DB01167">Itraconazole</a></td><td>The macrolide, josamycin, may increase the effect and toxicity of itraconazole.</td></tr><tr><td><a href="/drugs/DB01137">Levofloxacin</a></td><td>Increased risk of cardiotoxicity and arrhythmias</td></tr><tr><td><a href="/drugs/DB00227">Lovastatin</a></td><td>The macrolide, josamycin, may increase the toxicity of the statin, lovastatin.</td></tr><tr><td><a href="/drugs/DB00933">Mesoridazine</a></td><td>Increased risk of cardiotoxicity and arrhythmias</td></tr><tr><td><a href="/drugs/DB00247">Methysergide</a></td><td>Possible ergotism and severe ischemia with this combination</td></tr><tr><td><a href="/drugs/DB00683">Midazolam</a></td><td>The macrolide, josamycin, may increase the effect of the benzodiazepine, midazolam.</td></tr><tr><td><a href="/drugs/DB00218">Moxifloxacin</a></td><td>Increased risk of cardiotoxicity and arrhythmias</td></tr><tr><td><a href="/drugs/DB01303">Oxtriphylline</a></td><td>The macrolide, josamycin, may increase the effect and toxicity of the theophylline derivative, oxtriphylline.</td></tr><tr><td><a href="/drugs/DB01100">Pimozide</a></td><td>Increased risk of cardiotoxicity and arrhythmias</td></tr><tr><td><a href="/drugs/DB00912">Repaglinide</a></td><td>The macrolide, josamycin, may increase the effect of repaglinide.</td></tr><tr><td><a href="/drugs/DB00615">Rifabutin</a></td><td>The rifamycin, rifabutin, may decrease the effect of the macrolide, josamycin.</td></tr><tr><td><a href="/drugs/DB01045">Rifampicin</a></td><td>The rifamycin, rifampin, may decrease the effect of the macrolide, josamycin.</td></tr><tr><td><a href="/drugs/DB00342">Terfenadine</a></td><td>Increased risk of cardiotoxicity and arrhythmias</td></tr><tr><td><a href="/drugs/DB00277">Theophylline</a></td><td>The macrolide, josamycin, may increase the effect and toxicity of theophylline.</td></tr><tr><td><a href="/drugs/DB00679">Thioridazine</a></td><td>Increased risk of cardiotoxicity and arrhythmias</td></tr><tr><td><a href="/drugs/DB00897">Triazolam</a></td><td>The macrolide, josamycin, may increase the effect of the benzodiazepine, triazolam.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>